Portfolio (Quarterly)
Guide ↗
Blue Owl Capital Holdings LP
· CIK 0001858703| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | ENGENE HOLDINGS INC | — | 3,360,937.0 | $30.3M | 9.37% | NEW | — | $9.03 | — |
| 2 | NCDL | NUVEEN CHURCHILL DIRECT LEND | Financial Services | 2,143,626.0 | $28.6M | 8.82% | NEW | — | $13.34 | -1.3% |
| 3 | — | BLUE OWL CAPITAL CORPORATION | — | 2,045,070.0 | $26.1M | 8.06% | NEW | — | $12.77 | — |
| 4 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 6,823,690.0 | $26.0M | 8.02% | NEW | — | $3.81 | +2.1% |
| 5 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 2,350,972.0 | $24.3M | 7.51% | NEW | — | $10.35 | +52.0% |
| 6 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 3,466,525.0 | $18.6M | 5.75% | NEW | — | $5.37 | -65.4% |
| 7 | HLLY | HOLLEY INC | Consumer Cyclical | 4,146,636.0 | $17.1M | 5.29% | NEW | — | $4.13 | -34.1% |
| 8 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 7,432,906.0 | $10.9M | 3.37% | NEW | — | $1.47 | +46.9% |
| 9 | CNDT | CONDUENT INC | Technology | 4,822,422.0 | $9.3M | 2.86% | NEW | — | $1.92 | -27.6% |
| 10 | — | REPARE THERAPEUTICS INC | — | 3,443,659.0 | $9.0M | 2.76% | NEW | — | $2.60 | — |
| 11 | — | CIVEO CORP | — | 370,530.0 | $8.5M | 2.62% | NEW | — | $22.87 | — |
| 12 | SGMT | SAGIMET BIOSCIENCES INC | Healthcare | 1,243,877.0 | $7.4M | 2.27% | NEW | — | $5.92 | +24.5% |
| 13 | EYPT | EYEPOINT INC | Healthcare | 392,594.0 | $7.2M | 2.21% | NEW | — | $18.27 | -27.5% |
| 14 | PCOR | PROCORE TECHNOLOGIES INC | Technology | 94,264.0 | $6.9M | 2.12% | NEW | — | $72.74 | -36.0% |
| 15 | DELL | DELL TECHNOLOGIES INC | Technology | 53,848.0 | $6.8M | 2.09% | NEW | — | $125.88 | +96.9% |
| 16 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 360,000.0 | $5.8M | 1.79% | NEW | — | $16.15 | +65.7% |
| 17 | MPLT | MAPLIGHT THERAPEUTICS INC | Healthcare | 327,058.0 | $5.7M | 1.77% | NEW | — | $17.57 | +63.6% |
| 18 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 263,249.0 | $5.7M | 1.76% | NEW | — | $21.70 | +35.9% |
| 19 | IMA | IMAGENEBIO INC | Healthcare | 823,785.0 | $5.7M | 1.75% | NEW | — | $6.90 | -17.7% |
| 20 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 986,240.0 | $5.2M | 1.59% | NEW | — | $5.23 | +93.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
68.1%
Financial Services
13.3%
Technology
11.1%
Consumer Cyclical
7.0%
Energy
0.4%
Communication Services
0.0%
Consumer Defensive
0.0%